Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Xbrane Biopharma - Filing #679208

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
322 028 SEK
168 513 SEK
Revenue
238 729 SEK
57 618 SEK
Profit (loss) from discontinued operations
66 144 SEK
4 001 SEK
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities, discontinued operations
645,000 SEK
9 876 SEK
Cash flows from (used in) operating activities
406 678 SEK
193 918 SEK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities, discontinued operations
SEK
SEK
Cash flows from (used in) investing activities
16 769 SEK
60 125 SEK
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities, discontinued operations
SEK
SEK
Cash flows from (used in) financing activities
298 696 SEK
148 864 SEK
Increase (decrease) in cash and cash equivalents, discontinued operations
645,000 SEK
53,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.